AMN

SEC source: 0001209191-19-003381 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,152

F1 · kind: The sale of 5,246 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported represents a weighted average price of $59.4735 per share. These shares were sold in multiple transactions at prices ranging from $59.07 to $59.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-002919 · doc4.xml · derivative · entry 6

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,369

Underlying: Common Stock · 77,580 shares

Expires 2020-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: The exercise of derivative securities reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F7 · derivative.exercise_date: The SSARs set forth in this row were granted on February 2, 2010 pursuant to the AMN Healthcare Equity Plan and vested in three equal installments on the first, second and third anniversary of the grant date.

SEC source: 0001209191-19-002919 · doc4.xml · nonDerivative · entry 5

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,886

F4 · kind: The sale of 39,552 shares of AMN Common Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: The price reported in this row represents a weighted average price of $57.8953 per share. These shares were sold in multiple transactions at prices ranging from $57.305 to $58.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-002919 · doc4.xml · nonDerivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,438

F3 · shares: A Stock-Settled Appreciation Right ("SSAR") entitles the Grantee to the right to receive shares of AMN's Common Stock ("Stock") having a value equal to the excess of the Fair Market Value of the closing price of the Stock on the trading day prior to the date of exercise over the Exercise Price multiplied by the number of SSARs exercised. This number set forth in this row represents the difference between the number of SSARs exercised (77,580) and the number of shares of Stock issued as a result of the exercise (39,552).

SEC source: 0001209191-19-002919 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,466

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-19-002928 · doc4.xml · derivative · entry 9

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,050

Underlying: Common Stock · 1,009 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F9 · derivative.exercise_date: The RSUs set forth in this row were granted on January 5, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-002928 · doc4.xml · derivative · entry 8

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F8 · derivative.exercise_date: The RSUs set forth in this row were granted on January 5, 2016 and vest on the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-002928 · doc4.xml · nonDerivative · entry 6

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,398

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-002928 · doc4.xml · nonDerivative · entry 5

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,746

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-002928 · doc4.xml · nonDerivative · entry 4

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,737

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-002928 · doc4.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,266

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-002928 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,735

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-002928 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,810

F1 · kind: The acquisition of AMN Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2016. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2015 for the 3-year period beginning on January 1, 2016 and ended December 31, 2018 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 3, 2019. The Company's Relative TSR measured in the 84th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award, were deemed earned and vested.

SEC source: 0001209191-19-002924 · doc4.xml · derivative · entry 11

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,766

Underlying: Common Stock · 2,348 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F12 · derivative.exercise_date: The RSUs set forth in this row were granted on January 5, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-002924 · doc4.xml · derivative · entry 10

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,296 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F9 · derivative.exercise_date: The RSUs set forth in this row were granted on January 5, 2016 and vest on the grantee's provision of three periods of credited service.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-002924 · doc4.xml · derivative · entry 9

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 38,486 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The PRSUs set forth in this row were granted pursuant to the AMN Healthcare Equity Plan. Each PRSU represents a contingent right to receive one share of Common Stock.

F6 · derivative.exercise_date: The PRSUs set forth in this row were granted on January 5, 2015. If the average closing stock price of the Company's Common Stock during the second performance period from December 1, 2018 through December 31, 2018 equals or exceeds $29.20 per share, an additional 19,243 PRSUs shall vest and become earned.

F7 · derivative.expiration_date: PRSUs do not have an expiration date.

SEC source: 0001209191-19-002924 · doc4.xml · nonDerivative · entry 8

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,719

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-002924 · doc4.xml · nonDerivative · entry 7

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,642

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-002924 · doc4.xml · nonDerivative · entry 6

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,294

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-002924 · doc4.xml · nonDerivative · entry 5

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,197

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-002924 · doc4.xml · nonDerivative · entry 4

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,901

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-002924 · doc4.xml · nonDerivative · entry 3

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,240

F3 · kind: The acquisition of AMN Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2016. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2015 for the 3-year period beginning on January 1, 2016 and ended December 31, 2018 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 3, 2019. The Company's Relative TSR measured in the 84th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award, were deemed earned and vested.

SEC source: 0001209191-19-002924 · doc4.xml · nonDerivative · entry 2

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,754

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-002924 · doc4.xml · nonDerivative · entry 1

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,319

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2015. The ultimate number of PRSUs that could have been earned and vested under the second performance period was contingent upon whether the average closing price of the Company's Common Stock from December 1, 2018 through December 31, 2018 equaled or exceeded $29.20. The Compensation and Stock Plan Committee performed the calculation for this award on January 3, 2019 and determined that the average closing price of the Company's Common Stock during the second performance period exceeded $29.20 per share. Based on these results, an additional 19,243 PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-19-002926 · doc4.xml · derivative · entry 11

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,766

Underlying: Common Stock · 2,348 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F12 · derivative.exercise_date: The RSUs set forth in this row were granted on January 5, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-002926 · doc4.xml · derivative · entry 10

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,296 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F9 · derivative.exercise_date: The RSUs set forth in this row were granted on January 5, 2016 and vest on the grantee's provision of three periods of credited service.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-002926 · doc4.xml · derivative · entry 9

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 38,486 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The PRSUs set forth in this row were granted pursuant to the AMN Healthcare Equity Plan. Each PRSU represents a contingent right to receive one share of Common Stock.

F6 · derivative.exercise_date: The PRSUs set forth in this row were granted on January 5, 2015. If the average closing stock price of the Company's Common Stock during the second performance period from December 1, 2018 through December 31, 2018 equals or exceeds $29.20 per share, an additional 19,243 PRSUs shall vest and become earned.

F7 · derivative.expiration_date: PRSUs do not have an expiration date.

SEC source: 0001209191-19-002926 · doc4.xml · nonDerivative · entry 8

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,958

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-002926 · doc4.xml · nonDerivative · entry 7

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,122

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-002926 · doc4.xml · nonDerivative · entry 6

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,774

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-002926 · doc4.xml · nonDerivative · entry 5

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,912

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-002926 · doc4.xml · nonDerivative · entry 4

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,616

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-002926 · doc4.xml · nonDerivative · entry 3

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,823

F3 · kind: The acquisition of AMN Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2016. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2015 for the 3-year period beginning on January 1, 2016 and ended December 31, 2018 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 3, 2019. The Company's Relative TSR measured in the 84th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award, were deemed earned and vested.

SEC source: 0001209191-19-002926 · doc4.xml · nonDerivative · entry 2

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,337

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-002926 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,851

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2015. The ultimate number of PRSUs that could have been earned and vested under the second performance period was contingent upon whether the average closing price of the Company's Common Stock from December 1, 2018 through December 31, 2018 equaled or exceeded $29.20. The Compensation and Stock Plan Committee performed the calculation for this award on January 3, 2019 and determined that the average closing price of the Company's Common Stock during the second performance period exceeded $29.20 per share. Based on these results, an additional 19,243 PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-19-002919 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,886

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-002919 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,707

F1 · kind: The acquisition of common stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2016. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2015 for the 3-year period beginning on January 1, 2016 and ended December 31, 2018 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 3, 2019. The Company's Relative TSR measured in the 84th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award, were deemed earned and vested.

SEC source: 0001209191-19-002928 · doc4.xml · derivative · entry 7

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,057

Underlying: Common Stock · 4,057 shares

Expires not disclosed

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs set forth in this row were granted on January 3, 2019 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-002924 · doc4.xml · derivative · entry 12

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,352

Underlying: Common Stock · 6,352 shares

Expires not disclosed

F11 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F13 · derivative.exercise_date: The RSUs set forth in this row were granted on January 3, 2019 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-002926 · doc4.xml · derivative · entry 12

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,352

Underlying: Common Stock · 6,352 shares

Expires not disclosed

F11 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F13 · derivative.exercise_date: The RSUs set forth in this row were granted on January 3, 2019 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-001808 · doc4.xml · derivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 42,096 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The PRSUs set forth in this row were granted pursuant to the AMN Healthcare Equity Plan. Each PRSU represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The PRSUs set forth in this row resulted from the vesting of a PRSU award granted by the Company on January 3, 2014. On January 4, 2017, the maximum number of PRSUs that could have been earned, 42,096, were deemed earned and vested under this January 3, 2014 PRSU award.

F5 · derivative.expiration_date: PRSUs do not have an expiration date.

SEC source: 0001209191-19-001808 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,957

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-001808 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,885

F1 · kind: The acquisition of AMN Common Stock set forth in this row resulted from the deferred release of a Performance Restricted Stock Unit ("PRSU") award that vested on January 4, 2017. In 2014, the reporting person elected to defer receipt of these PRSUs pursuant to the Company's deferred compensation plan, with a settlement date of January 2, 2019.

SEC source: 0001209191-18-063508 · doc4.xml · derivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,187

Underlying: Common Stock · 22,187 shares

Expires not disclosed

F2 · derivative.exercise_price: The Restricted Stock Units ("RSUs") set forth in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs were granted on December 17, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-18-062547 · doc4.xml · nonDerivative · entry 1

STERN ANDREW M · CIK 0001158585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,668

F1 · kind: The reporting person transferred 2,000 shares of AMN Common Stock as a gift to charity.

SEC source: 0001209191-18-060778 · doc4.xml · nonDerivative · entry 1

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,022

SEC source: 0001209191-18-060511 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,365

F1 · price: The price reported in this row represents a weighted average price of $64.248 per share. These shares were sold in multiple transactions at prices ranging from $64.11 to $64.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-18-060428 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,152

SEC source: 0001209191-18-057352 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,789

F1 · kind: The sale of 11,953 shares of Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $56.4871 per share. These shares were sold in multiple transactions at prices ranging from $55.60 to $58.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-18-038738 · doc4.xml · nonDerivative · entry 2

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,865

F3 · kind: The sale of 7,500 shares of AMN Common Stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported in this row represents a weighted average price of $60.0091 per share. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.